Abacavir, Dolutegravir and Lamivudine Dispersible Tablets (60 mg/5 mg/30 mg)

Clinical trial NCT05030025 · COMPLETED

Trial details

NCT number: NCT05030025
Sponsor: Mylan Inc.
Status: COMPLETED
Phase: Early Phase 1
Study type: INTERVENTIONAL

HIV-1-infection

Start date: 2021-08-01
Primary completion: 2021-08-29
Enrollment: 43

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.